Literature DB >> 23793138

Lack of value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 for prediction of severe bacterial infections in infants with fever without a source.

Javier Benito1, Carlos Luaces-Cubells, Santiago Mintegi, Eider Astobiza, Lorea Martinez-Indart, Ana Valls-Lafont, Juan-José García-García.   

Abstract

UNLABELLED: The study was performed to assess the usefulness of two new biomarkers, midregional pro-adrenomedullin (MR-pro-ADM) and C-pro-endothelin-1 (CT-pro-ET-1), in predicting bacterial infection (BI) and especially invasive bacterial infection (IBI) in well-appearing infants with fever without source (FWS). For this purpose, a multicenter prospective study was conducted between February 2008 and March 2009 including well-appearing infants less than 36 months of age with FWS. MR-pro-ADM, CT-pro-ET-1, procalcitonin (PCT), CRP, and WBC were measured and compared. Among the 1,035 infants included, a bacterial infection was diagnosed in 75 patients (7.2 %), and 16 (1.54 %) had an invasive bacterial infection (bacterial meningitis, 8; occult bacteremia, 6; and sepsis, 1). MR-pro-ADM and CT-pro-ET-1 levels were less reliable for diagnosis than the other biomarkers. The area under receiver operating characteristic curve for infants with BI and IBI was 0.59 (95 % confidence interval (CI) 0.52-0.67) and 0.63 (95 % CI 0.46-0.80) for MR-pro-ADM and 0.58 (95 % CI 0.51-0.66) and 0.62 (95 % CI 0.47-0.67) for CT-pro-ET-1, respectively. Multivariate analysis showed that PCT ≥ 0.5 ng/mL, CRP ≥ 40 mg/L, and CT-pro-ET-1 ≥ 105 pmol/mL were independent risk factors for having a BI (odds ratio (OR) 6.12, 3.61, and 2.84, respectively). PCT was the only independent risk factor for having an IBI (OR 17.53 if PCT ≥ 0.5 ng/mL).
CONCLUSION: Although baseline MR-pro-ADM and CT-pro-ET-1 levels are significantly elevated in well-appearing febrile infants with a bacterial infection, their overall performance as diagnostic markers is very poor.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793138     DOI: 10.1007/s00431-013-2062-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  28 in total

1.  Editorial: Clinical policy for children younger than three years presenting to the emergency department with fever.

Authors:  Larry J Baraff
Journal:  Ann Emerg Med       Date:  2003-10       Impact factor: 5.721

Review 2.  In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus?

Authors:  David Herd
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

3.  Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma.

Authors:  Jana Papassotiriou; Nils G Morgenthaler; Joachim Struck; Christine Alonso; Andreas Bergmann
Journal:  Clin Chem       Date:  2006-04-20       Impact factor: 8.327

Review 4.  Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children.

Authors:  Allen L Hsiao; M Douglas Baker
Journal:  Curr Opin Pediatr       Date:  2005-02       Impact factor: 2.856

5.  Proteolytic processing pattern of the endothelin-1 precursor in vivo.

Authors:  Joachim Struck; Nils G Morgenthaler; Andreas Bergmann
Journal:  Peptides       Date:  2005-06-22       Impact factor: 3.750

Review 6.  Evaluation of the infant with fever without source: an evidence based approach.

Authors:  M Slater; S E Krug
Journal:  Emerg Med Clin North Am       Date:  1999-02       Impact factor: 2.264

7.  Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center.

Authors:  Annick Galetto-Lacour; Samuel A Zamora; Alain Gervaix
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

8.  Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.

Authors:  Mirjam Christ-Crain; Nils G Morgenthaler; Joachim Struck; Stephan Harbarth; Andreas Bergmann; Beat Müller
Journal:  Crit Care       Date:  2005-11-15       Impact factor: 9.097

9.  Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Nils G Morgenthaler; Joachim Struck; Andreas Bergmann; Beat Müller
Journal:  Endothelium       Date:  2007 Nov-Dec

10.  Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia.

Authors:  Philipp Schuetz; Daiana Stolz; Beat Mueller; Nils G Morgenthaler; Joachim Struck; Christian Mueller; Roland Bingisser; Michael Tamm; Mirjam Christ-Crain
Journal:  BMC Infect Dis       Date:  2008-02-28       Impact factor: 3.090

View more
  6 in total

1.  Is pro-adrenomedullin a more useful marker in hospitalized infants with sepsis?

Authors:  Mehmet Yekta Oncel; Omer Erdeve; Nurdan Uras; Ugur Dilmen
Journal:  Eur J Pediatr       Date:  2013-08-17       Impact factor: 3.183

2.  Reply to correspondence letter: is pro-adrenomedullin more useful marker in hospitalized infants with sepsis?

Authors:  Javier Benito-Fernández
Journal:  Eur J Pediatr       Date:  2013-08-16       Impact factor: 3.183

3.  Candidate Biomarkers for the Detection of Serious Infections in Children: A Prospective Clinical Study.

Authors:  Maria Chiara Pellegrin; Arturo Penco; Leonardo Amadio; Samuele Naviglio; Luigina De Leo; Oriano Radillo; Gianni Biolo; Nicola Fiotti; Filippo Mearelli; Marco Rabusin; Egidio Barbi; Lorenzo Monasta
Journal:  Children (Basel)       Date:  2022-05-07

4.  Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis.

Authors:  Sameh Samir Fahmey; Heba Mostafa; Noha Abd Elhafeez; Heba Hussain
Journal:  Korean J Pediatr       Date:  2018-05-28

5.  Diagnostic value of mid-regional pro-Adrenomedullin as a biomarker of invasive bacterial infection in children: a systematic review.

Authors:  Michael Paul Corr; Derek Fairley; James P McKenna; Michael D Shields; Thomas Waterfield
Journal:  BMC Pediatr       Date:  2022-04-04       Impact factor: 2.125

Review 6.  A Review of Adrenomedullin in Pediatric Patients: A Useful Biomarker.

Authors:  Anna Solé-Ribalta; Sara Bobillo-Pérez; Iolanda Jordan-García
Journal:  Children (Basel)       Date:  2022-08-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.